Olivier Leclerc is a Senior Partner in the Southern California Office of McKinsey & Company. He serves pharmaceutical, biotech, and medical products clients on strategic and operational improvement issues.
His pharmaceutical and medical device clients range from multi-billion-dollar corporations to pre-IPO biotech companies. He also serves investment firms focused on healthcare investments. His recent experience includes studies in portfolio prioritization for early stage technologies, product launch strategy, sales and marketing, post-merger management, and pricing/reimbursement.
Olivier leads McKinsey Oncology Service Line in the US and has deep expertise in specialty pharmaceuticals, as well as pricing/contracting across healthcare sectors. He also leads McKinsey’s Digital Service line in the pharmaceutical and medical device sector.
Prior to joining McKinsey, Olivier worked in Hong Kong and China for 3 years in sales and marketing for two consumer product companies. He holds an MBA from Harvard Business School, a B.A. in business and economics from HEC in France, a J.D. in French Corporate and Tax Law from the University of Paris, and a D.E.C.F. (French Degree in Finance and Accounting).
